ChengDa Pharmaceuticals Co. Ltd. Net Asset Quality Index
ChengDa Pharmaceuticals Co. Ltd. net asset quality index. ChengDa Pharmaceuticals Co. Ltd. (301201) has a Net Asset Quality Index of 89.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.35 Billion minus total liabilities of CN¥251.32 Million yields net assets of CN¥2.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 301201 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Net asset quality index of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025. This chart shows how ChengDa Pharmaceuticals Co. Ltd.'s Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 89.3%, representing net assets of CN¥2.10 Billion against total assets of CN¥2.35 Billion CNY. See ChengDa Pharmaceuticals Co. Ltd. shareholders equity for net asset value and shareholders' equity analysis.
ChengDa Pharmaceuticals Co. Ltd. Net Asset Quality Index by Year (2019–2025)
ChengDa Pharmaceuticals Co. Ltd. net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 301201 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.2% | CN¥2.10 Billion | CN¥2.35 Billion | CN¥252.83 Million | ▲ +1.2 pp |
| 2024 | 88.1% | CN¥2.15 Billion | CN¥2.44 Billion | CN¥290.77 Million | ▼ -4.7 pp |
| 2023 | 92.8% | CN¥2.28 Billion | CN¥2.46 Billion | CN¥176.40 Million | ▼ -2.6 pp |
| 2022 | 95.4% | CN¥2.22 Billion | CN¥2.32 Billion | CN¥105.81 Million | ▲ +17.9 pp |
| 2021 | 77.6% | CN¥529.93 Million | CN¥683.23 Million | CN¥153.30 Million | ▼ -8.3 pp |
| 2020 | 85.9% | CN¥458.91 Million | CN¥534.21 Million | CN¥75.30 Million | ▲ +20.5 pp |
| 2019 | 65.4% | CN¥357.35 Million | CN¥546.56 Million | CN¥189.21 Million | — |